Emergent BioSolutions Inc. <EBS.N>: H.C. Wainwright cuts target price to $10 from $12
EBS•Related News
India seizes thousands of Diageo whisky, vodka bottles in food safety crackdown
DEO•
Dollar steadies after payrolls drop, yen falls
SPY•
Instinct Bio partners with Indonesia’s Parva Candela to expand cosmetics business
BIOT•
Oruka Therapeutics Q2 FY26 net loss widens to $41.2 million; R&D expenses rise to $43.3 million
ORKA•
MBX Biosciences, Inc. <MBX.O>: Truist Securities raises target price to $88 from $70
MBX•